Titre:
  • Results of the Belgian expanded access program of eribulin in the treatment of metastatic breast cancer closely mirror those of the pivotal phase III trial
Auteur:Aftimos, Philippe; Polastro, Laura; Ameye, Lieveke; Jungels, C.; Vakili, Jalal; Paesmans, Marianne; Van Den Eerenbeemt, Joanne; Buttice, A; Gombos, Andrea; De Valeriola, Dominique; Gil, Thierry; Piccart-Gebhart, Martine; Awada, Ahmad
Informations sur la publication:European journal of cancer, 60, page (117-124)
Statut de publication:Publié, 2016-06
Sujet CREF:Cancérologie
Mots-clés:Breast cancer
Chemotherapy
Cross-resistance
Eribulin
Metastatic
Safety
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0959-8049
info:doi/10.1016/j.ejca.2016.03.010
info:pii/S0959804916001866
info:scp/84964342351